PZLV applies Pzena Investment Management's deep value philosophy to U.S. large caps, hunting for stocks trading at significant discounts to normalized earnings. This ETF targets companies the market has given up on but where Pzena sees hidden earnings power.
How It Works
The fund employs Pzena's classic value approach: screening for stocks with low price-to-normalized earnings ratios, then conducting fundamental analysis to identify companies with sustainable competitive advantages trading below intrinsic value. Holdings are concentrated in 30-50 positions, weighted by conviction rather than market cap. The portfolio rebalances quarterly as valuations change and new opportunities emerge.
Key Features
- Concentrated portfolio of 30-50 deep value picks versus 600+ holdings in typical value indexes
- Uses normalized earnings to identify temporarily depressed stocks that screens miss
- Active management in ETF wrapper at competitive pricing versus mutual fund alternatives
Risks
- Value traps where cheap stocks stay cheap or get cheaper — concentrated bets magnify this pain
- Style risk during growth rallies when value lags by 10-20% annually for multiple years
- Manager risk if Pzena's stock picking falters — no index diversification to cushion bad calls
Who Should Own This
Best suited for patient investors who believe in mean reversion and can stomach years of underperformance waiting for value to work. Works as a satellite holding (5-10% of equity allocation) for those wanting concentrated value exposure beyond what broad market ETFs provide. Not for momentum chasers or anyone who'll bail after six months of lagging the S&P.